Skip to main content
KBG Corp. logo

KBG Corp. — Investor Relations & Filings

Ticker · 318000 ISIN · KR7318000007 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2021-03-16 Annual Report
Country KR South Korea
Listing KO 318000

About KBG Corp.

http://www.kbgtech.co.kr/en/index.php

KBG Corp. is a fine chemical company specializing in the development, manufacturing, and distribution of silicone-based materials. The company's product portfolio encompasses a wide range of inorganic and organic silicon chemicals, including silane monomers, silane coupling agents, silane crosslinking agents, silicone resins, and reactive silicone fluids. KBG Corp. also produces catalysts for silicone curing and advanced silicone materials specifically designed for the electronics sector and other fusion material applications. The company serves a global customer base.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 20th fiscal year (2020) of Korea Bio-Gen Co., Ltd. It contains detailed sections on company overview, history, capital changes, shareholding structure, dividend history, and business operations. This structure corresponds to the standard annual financial and operational disclosure required by regulatory bodies (Financial Services Commission/Korea Exchange), which is classified as an Annual Report (10-K) in this taxonomy. FY 2020
2021-03-16 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean market (DART system) regarding a correction (amendment) to a previously filed report on financial performance (specifically, a change in revenue or profit/loss structure of 30% or more). Since this is a formal regulatory announcement of financial data updates rather than a full annual report or a simple publication notice, it falls under the 'Regulatory Filings' category as a catch-all for specific corporate disclosures that do not fit into the other specialized categories. FY 2020
2021-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Korea Biogen Co., Ltd. It contains the agenda for the 20th Annual General Meeting, including financial statement approval, director appointments, and dividend proposals. It also includes detailed financial statements (balance sheet, income statement, cash flow, etc.) as part of the management's reference materials for the meeting. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information and agenda items to vote on at the upcoming meeting.
2021-03-09 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '한국바이오젠'. It outlines the date, location, and agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2021-02-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (한국바이오젠) announcing a significant change in financial results (revenue or profit/loss structure change of 30% or more). This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results before the final audit is completed. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the Earnings Release (ER) category. FY 2020
2021-02-09 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from '한국바이오젠' (Korea Biogen) regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2021-02-09 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.